Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
2.3. Scope Of Study
2.4. Crisis Scenario Analysis
2.5. Major Market Findings
2.5.1. Increasing Application Of Ai And Machine Learning In Skin Cancer Diagnosis Tools

3. Market Dynamics
3.1. Key Drivers
3.1.1. Increasing Prevalence Of Skin Cancer
3.1.2. Growing Awareness About Skin Cancer Diagnosis & Treatment
3.1.3. Technological Advancements In Skin Cancer Diagnostic Products
3.2. Key Restraints
3.2.1. High Costs Associated With Skin Cancer Treatments
3.2.2. Stringent Regulatory Framework
3.2.3. Lack Of Skilled Medical Professionals

4. Key Analytics
4.1. Parent Market Analysis
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Growth Prospect Mapping
4.5. Market Concentration Analysis
4.6. Value Chain Analysis
4.6.1. Research And Development
4.6.2. Manufacturing
4.6.3. Marketing And Sales
4.6.4. Distribution And Logistics
4.6.5. Training And Support

5. Market By Type
5.1. Melanoma
5.2. Non-Melanoma

6. Market By Gender
6.1. Male
6.2. Female

7. Market By Screening Type
7.1. Skin Biopsy
7.2. Dermatoscopy
7.3. Lymph Node
7.4. Biopsy Imaging Tests
7.5. Blood Tests

8. Geographical Analysis
8.1. Europe
8.1.1. Market Size & Estimates
8.1.2. Europe Skin Cancer Diagnostics Market Drivers
8.1.3. Europe Skin Cancer Diagnostics Market Challenges
8.1.4. Key Players In Europe Skin Cancer Diagnostics Market
8.1.5. Country Analysis
8.1.5.1. United Kingdom
8.1.5.1.1. United Kingdom Skin Cancer Diagnostics Market Size & Opportunities
8.1.5.2. Germany
8.1.5.2.1. Germany Skin Cancer Diagnostics Market Size & Opportunities
8.1.5.3. France
8.1.5.3.1. France Skin Cancer Diagnostics Market Size & Opportunities
8.1.5.4. Italy
8.1.5.4.1. Italy Skin Cancer Diagnostics Market Size & Opportunities
8.1.5.5. Spain
8.1.5.5.1. Spain Skin Cancer Diagnostics Market Size & Opportunities
8.1.5.6. Nordic Countries
8.1.5.6.1. Nordic Countries Skin Cancer Diagnostics Market Size & Opportunities
8.1.5.7. Belgium
8.1.5.7.1. Belgium Skin Cancer Diagnostics Market Size & Opportunities
8.1.5.8. Poland
8.1.5.8.1. Poland Skin Cancer Diagnostics Market Size & Opportunities
8.1.5.9. Rest Of Europe
8.1.5.9.1. Rest Of Europe Skin Cancer Diagnostics Market Size & Opportunities

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Product Launches & Developments
9.1.2. Partnerships & Agreements
9.2. Company Profiles
9.2.1. Amlo Biosciences Limited
9.2.2. Biomerieux Sa
9.2.3. Castle Biosciences Inc
9.2.4. Dermlite Llc
9.2.5. Dermtech Inc.
9.2.6. F. Hoffmann-La Roche Ltd
9.2.7. Michelson Diagnostics Ltd
9.2.8. Neracare Gmbh
9.2.9. Skylinedx Bv
9.2.10. Veriskin Inc



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Growth Prospect Mapping For Europe
Figure 4: Market Concentration Analysis
Figure 5: Value Chain Analysis
Figure 6: Europe Skin Cancer Diagnostics Market, Growth Potential, By Type, In 2022
Figure 7: Europe Skin Cancer Diagnostics Market, By Melanoma, 2023-2032 (In $ Million)
Figure 8: Europe Skin Cancer Diagnostics Market, By Non-Melanoma, 2023-2032 (In $ Million)
Figure 9: Europe Skin Cancer Diagnostics Market, Growth Potential, By Gender, In 2022
Figure 10: Europe Skin Cancer Diagnostics Market, By Male, 2023-2032 (In $ Million)
Figure 11: Europe Skin Cancer Diagnostics Market, By Female, 2023-2032 (In $ Million)
Figure 12: Europe Skin Cancer Diagnostics Market, Growth Potential, By Screening Type, In 2022
Figure 13: Europe Skin Cancer Diagnostics Market, By Skin Biopsy, 2023-2032 (In $ Million)
Figure 14: Europe Skin Cancer Diagnostics Market, By Dermatoscopy, 2023-2032 (In $ Million)
Figure 15: Europe Skin Cancer Diagnostics Market, By Lymph Node, 2023-2032 (In $ Million)
Figure 16: Europe Skin Cancer Diagnostics Market, By Biopsy Imaging Tests, 2023-2032 (In $ Million)
Figure 17: Europe Skin Cancer Diagnostics Market, By Blood Tests, 2023-2032 (In $ Million)
Figure 18: Europe Skin Cancer Diagnostics Market, Country Outlook, 2022 & 2032 (In %)
Figure 19: United Kingdom Skin Cancer Diagnostics Market, 2023-2032 (In $ Million)
Figure 20: Germany Skin Cancer Diagnostics Market, 2023-2032 (In $ Million)
Figure 21: France Skin Cancer Diagnostics Market, 2023-2032 (In $ Million)
Figure 22: Italy Skin Cancer Diagnostics Market, 2023-2032 (In $ Million)
Figure 23: Spain Skin Cancer Diagnostics Market, 2023-2032 (In $ Million)
Figure 24: Nordic Countries Skin Cancer Diagnostics Market, 2023-2032 (In $ Million)
Figure 25: Belgium Skin Cancer Diagnostics Market, 2023-2032 (In $ Million)
Figure 26: Poland Skin Cancer Diagnostics Market, 2023-2032 (In $ Million)
Figure 27: Rest Of Europe Skin Cancer Diagnostics Market, 2023-2032 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – SKIN CANCER DIAGNOSTICS
TABLE 2: EUROPE SKIN CANCER DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: EUROPE SKIN CANCER DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: EUROPE SKIN CANCER DIAGNOSTICS MARKET, BY GENDER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: EUROPE SKIN CANCER DIAGNOSTICS MARKET, BY GENDER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: EUROPE SKIN CANCER DIAGNOSTICS MARKET, BY SCREENING TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: EUROPE SKIN CANCER DIAGNOSTICS MARKET, BY SCREENING TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: EUROPE SKIN CANCER DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: EUROPE SKIN CANCER DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: KEY PLAYERS OPERATING IN EUROPE SKIN CANCER DIAGNOSTICS MARKET
TABLE 11: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 12: LIST OF PARTNERSHIPS & AGREEMENTS